A Legacy Born of Medicine

Some people inherit a house, a business, or land. Randeep Guleria inherited a stethoscope's worth of purpose. Born on 5 April 1959 in Kangra, Himachal Pradesh, he arrived into a family where medicine was not a career choice but a way of life already lived. His father, Dr. Jagdev Singh Guleria, was a respected general physician, a former Dean, and a long-serving Professor at the All India Institute of Medical Sciences (AIIMS), New Delhi — a man honoured with the Padma Shri for his own contributions to Indian medicine. Growing up in such a household meant that conversations at the dinner table likely drifted, more often than not, toward patients, diagnoses, and the quiet dignity of healing.

It would have been easy for young Randeep to simply walk into his father's shadow — to use the family name as a shortcut, to coast on inherited respect. He did not. Instead, he built his own path, step by careful step, through some of India's most demanding medical institutions, until his name became inseparable from his father's not because of blood, but because of parallel achievement.

He completed his schooling at St. Columba's School in Delhi in 1975, a formative institution known for producing disciplined, well-rounded students. From there, rather than staying in the comfort of Delhi, he chose to pursue his undergraduate medical degree at Indira Gandhi Medical College (IGMC) in Shimla, affiliated with Himachal Pradesh University — closer to his roots in the hills, and a place where he would have to prove himself entirely on his own merit, away from any institutional familiarity his father's name might have offered him in the capital.

The Making of a Specialist

After his MBBS, Guleria moved to the Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh — one of India's most competitive and rigorous medical training grounds. There, he completed his MD in General Medicine in 1986, and continued on to complete a DM in Pulmonary Medicine in 1991. This was not a common or easy road. Pulmonary and critical care medicine, as a distinct super-specialty, was barely established in India at the time. Guleria became the first Indian ever to earn a Doctorate of Medicine (DM) specifically in Pulmonary and Critical Care Medicine — a pioneering achievement that meant he was, in many ways, defining the shape of a new medical field in his own country rather than simply joining an existing one.

Between 1984 and 1992, he worked as an assistant professor at PGI Chandigarh, quietly building his clinical expertise and his teaching skill in equal measure. These were the unglamorous years — the ones that rarely make it into biographical summaries, but which form the actual bedrock of any serious medical career. Long hours in wards, endless rounds, research papers drafted late into the night, and the slow accumulation of clinical judgment that no textbook can fully teach.

Joining AIIMS: A Homecoming and a Beginning

In 1992, Guleria joined AIIMS, New Delhi — the same institution where his father had once served as Dean — but he entered not as an inheritor, but as an Assistant Professor in the Department of Medicine, at the bottom rung of a very long ladder. Over the following years, he was promoted steadily: to Associate Professor, then Additional Professor, and finally to full Professor and Head of the Department of Pulmonology and Sleep Disorders. This was not a fast climb. It was two decades of sustained, visible clinical work, teaching, and research before he reached the top of his department.

His most defining institutional achievement came in 2011, when he established India's first dedicated centre for pulmonary diseases and sleep disorders at AIIMS. Before this, patients with complex respiratory and sleep-related illnesses in India often had nowhere comprehensive to turn — care was fragmented, spread across general medicine wards without the specialized infrastructure such conditions demanded. Guleria changed that single-handedly, building not just a department, but an entire ecosystem of pulmonary care that other institutions across India would later look to as a model.

Under his leadership, the Department of Pulmonary Medicine and Sleep Disorders at AIIMS was recognized as the best department in pulmonary medicine for three consecutive years — 2014, 2015, and 2016 — according to the NIELSEN survey. This was not a single moment of glory but sustained excellence, year after year, under his direct stewardship.

His growing reputation also carried him into unexpected corridors of responsibility. He became the personal physician to former Prime Minister Atal Bihari Vajpayee starting in 1998, a role that placed enormous trust and pressure on a still-developing career. He also worked as a consultant to the International Atomic Energy Agency (IAEA) in Vienna on matters of radiation protection, and served as a member of the World Health Organization's Scientific Advisory Group of Experts (SAGE) on immunization and influenza vaccines — a position that gave him a genuinely global perspective on public health long before most Indians had heard his name.

Recognition That Came the Hard Way

By the time national recognition arrived, it was overdue rather than premature. In 2014, he received the Dr. B.C. Roy National Award for Eminent Medical Person — one of the highest honours in Indian medicine, named after the physician-statesman whose birthday is celebrated as National Doctors' Day. The following year, in 2015, he was conferred the Padma Shri, India's fourth-highest civilian award, in recognition of his contributions to the field of medicine. He also received the Lung India Award for the best original article from the Indian Chest Society, and was later honoured with a Doctor of Science (D.Sc.) Honoris Causa.

None of these honours came from a single dramatic breakthrough. They were the accumulated weight of a career built on thousands of patients treated, hundreds of students mentored, and a body of medical research and editorial contribution — including service on the editorial boards of journals such as the Indian Journal of Chest Diseases, Lung India, JAMA, and Chest — that quietly shaped the direction of respiratory medicine in India.

Taking the Helm of AIIMS

In March 2017, Guleria was appointed Director of AIIMS, New Delhi — succeeding Dr. M.C. Misra and taking charge of what is arguably the single most important and most scrutinized medical institution in the country. Leading AIIMS is not simply an administrative posting. It means overseeing one of the largest, busiest, most resource-strained hospital systems in the world, serving not just Delhi but patients who travel from every corner of India, often as a last resort after being failed elsewhere. It means balancing clinical care, medical education, research output, government expectations, media scrutiny, and the sheer logistics of running a city-sized institution — all at once.

He would hold this post until March 2022, a five-year tenure that happened to coincide with the most severe global health crisis of the modern era.

When the World Stopped: The COVID-19 Years

Nothing in Guleria's earlier career — not the decades of pulmonary research, not the international consultancies, not even his role as physician to a former Prime Minister — could have fully prepared him, or anyone, for what arrived in early 2020. As COVID-19 began spreading across India, AIIMS Delhi was thrust into the centre of the national response, and Guleria, as its Director, found himself simultaneously running a hospital under siege and serving as one of the most trusted public faces of India's fight against the pandemic.

He was appointed a member of the National Task Force and the Empowered Group constituted by the Government of India to guide the country's COVID-19 response — bodies responsible for shaping clinical treatment protocols, resource allocation, and public health strategy during a period when scientific understanding of the virus itself was evolving almost weekly. This was uncertain, high-pressure work. Early in the pandemic, there was no settled consensus on how the virus spread, how it should be treated, or how severe it would ultimately prove to be. Task force members had to make consequential recommendations based on incomplete and rapidly changing information, knowing that lives depended on getting it right, and that any error would be judged in hindsight with the full clarity that hadn't existed in the moment.

As Director of AIIMS, Guleria had to convert the country's flagship hospital into a frontline COVID treatment centre almost overnight — expanding intensive care capacity, reorganizing wards, protecting exhausted staff, and ensuring that non-COVID patients weren't entirely abandoned in the process. He did this while the world outside was gripped by fear, misinformation, and the visible strain of overwhelmed healthcare systems. Oxygen shortages, bed crunches during the devastating second wave, and the emotional toll on healthcare workers were realities he had to manage not from a distance, but from the operational centre of one of the institutions most exposed to all of it.

What set Guleria apart during this period was not just his administrative handling of the crisis, but the public role he took on almost by necessity. In a country of over a billion people, where panic could spread as fast as the virus itself, his calm, measured, scientifically grounded voice became a fixture in press briefings, television interviews, and public health communications. He explained, again and again, in language ordinary people could understand, what was known and unknown about the virus — how it spread, what precautions actually mattered, why vaccines were safe, why certain unproven remedies circulating on social media were not to be trusted. At a time when misinformation was arguably as dangerous as the virus itself, this steady clarity was its own form of public service.

His long-standing role with the WHO's advisory group on immunization and vaccines gave him a genuinely informed vantage point on vaccine science, which he brought directly into India's own vaccination rollout strategy — one of the largest vaccination campaigns ever undertaken by any country, delivered under enormous time pressure and logistical complexity. His voice helped build public trust in a vaccination programme that ultimately reached hundreds of millions of people.

The Weight Behind the Calm

It would be a disservice to Guleria's story to suggest that any of this came easily. Behind the composed public persona was a man making decisions under conditions no medical administrator is ever fully trained for. Every day carried the possibility of being second-guessed, criticized, or blamed — by the public, by media, by political actors — regardless of how sound the underlying science was. Running AIIMS during ordinary times is demanding; running it as the nerve centre of a national pandemic response, while also serving on government task forces shaping country-wide policy, is the kind of sustained pressure that tests not just professional competence but personal endurance.

There were no easy days during the second wave of 2021, when India's healthcare system came under the most severe strain in its modern history. Hospitals nationwide, including AIIMS, faced desperate shortages even as demand surged uncontrollably. Guleria had to lead through this not with the benefit of hindsight, but in real time, often having to communicate difficult truths to a frightened public while simultaneously managing the internal chaos of an overwhelmed institution. That he maintained both operational stability at AIIMS and public credibility throughout this period says a great deal about the reserves of resilience built over decades of clinical discipline.

Life After the Storm

When his tenure as AIIMS Director concluded in March 2022, succeeded by Dr. M. Srinivas, Guleria did not retreat from medicine. He went on to become Chairman of the Institute of Internal Medicine and Respiratory and Sleep Medicine, and Director of Medanta Medical School — continuing the same mission that had defined his entire career: building institutional capacity in respiratory and pulmonary care, training the next generation of physicians, and ensuring that the specialty he had helped pioneer in India continued to grow long after his own tenure at any single institution ended.

A Life That Adds Up

Dr. Randeep Guleria's story is not one of a single dramatic triumph, but of decades of consistent, disciplined contribution — from being India's first DM in Pulmonary and Critical Care Medicine, to building the country's first dedicated pulmonary and sleep disorders centre, to leading its most important hospital through its most difficult chapter. His achievements — the Padma Shri, the Dr. B.C. Roy Award, the international appointments — are markers along a much longer journey defined less by individual milestones and more by the sustained weight of responsibility he carried, especially when the entire country needed steady hands and a steady voice the most.

In many ways, his greatest contribution during the COVID-19 pandemic wasn't a single policy or protocol, but the simple, difficult work of staying calm and clear when nothing else was — leading an overwhelmed institution, guiding national policy under uncertainty, and speaking to a frightened nation with the measured authority of someone who had spent forty years earning the right to be trusted.